On July 12, 2011, the FDA released a new draft guidance on the development and review of companion diagnostics (CDx). I would encourage anyone working in anatomic pathology to review the draft, as it will have widespread impact on digital pathology companies, antibody providers, and anatomic pathologists in both private practices and large reference laboratories. The [...]
January 17, 2011 – 7:08 pm Quantitative dermatopathology is just scratching the surface with digital pathology
By Steve Potts | Also posted in dermatology, Image analysis in CAP and CLIA regulated laboratories, large pharma, medical devices, skin, small biotech | Tagged aarhus university, comparative pathology, dermatology, dermatopathology, digital pathology, fluorescence scanning, image analysis, Multiplexed IHC, ophthalmology, proliferation, scanning technology, university in denmark, university of pittsburg | December 27, 2010 – 11:00 pm At a molecular imaging meeting earlier this year, Flagship presented pharma regulatory compliance for digital pathology. Our talk was the only one on pathology. The others were all various presentations on the different modalities of radiology imaging applied to clinical trials — X-ray, MRIs, microCT scans, PET scans, CAT scans, dog scans, and so on A [...]
By Steve Potts | Also posted in HUMOR | Tagged Aperio, breast cancer, clinical trials, companion diagnostics, computer aided diagnosis, digital pathology, HER2, molecular imaging, multiplexing IHC, pattern recognition, pet scans, quantitative evaluation, Quantitative IHC, quantitative science, radiologist, radiology technology, recognition programs, regulatory compliance, rsna, tissue biomarker, tissue biomarkers | 
